- Both NMN (Nicotinamide Mononucleotide) and NR (Nicotinamide Riboside) are precursors that boost NAD+ levels, a critical molecule that declines with age
- NMN is one step closer to NAD+ in the metabolic pathway, while NR must first convert to NMN before becoming NAD+
- NR has more human clinical research to date, while NMN has shown particularly promising results in animal studies
- Your specific health goals, budget, and personal response may determine which supplement is better for you
- Some biohackers combine or cycle between both compounds for potentially complementary effects
Table of Contents
- Introduction: The NAD+ Controversy
- Understanding the Basics: NAD+, NMN, and NR
- Biochemical Differences: How They Work in Your Body
- Research Comparison: What Science Says
- Animal Studies: Where They Differ
- Human Research: The Current Evidence
- Head-to-Head Comparison: NMN vs. NR
- Practical Considerations: Cost, Dosage, and Availability
- Who Benefits Most: Matching Supplements to Goals
- The Combination Approach: Can You Take Both?
- Future Research: What’s on the Horizon
- Conclusion: Making Your Decision
- References
Introduction: The NAD+ Controversy
The quest for effective anti-aging interventions has led to the emergence of NAD+ precursors as some of the most promising compounds in the longevity field. Among these, two molecules have risen to prominence: Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR).
For those looking to optimize their longevity strategy, choosing between these two supplements can be challenging. Both claim to boost NAD+ levels, both have scientific research supporting their use, and both have vocal proponents in the scientific and biohacking communities.
Dr. David Sinclair of Harvard Medical School, a leading longevity researcher, favors NMN in his own regimen, while Dr. Charles Brenner, who discovered NR’s pathway to NAD+, advocates for NR. This has created what some call the “NAD+ precursor controversy” — a scientific debate about which molecule offers superior benefits.
The truth, as we’ll explore in this article, is nuanced. Both compounds have distinct properties, advantages, and potential applications depending on your specific health goals, age, and biological factors. Understanding these differences is crucial for making an informed decision about which NAD+ precursor might be right for your personal longevity strategy.
Let’s dive deep into the science, research, and practical considerations to help you navigate this complex but fascinating area of longevity science.
Understanding the Basics: NAD+, NMN, and NR
Before comparing NMN and NR directly, it’s essential to understand their relationship to NAD+ and why boosting this molecule is of interest in the first place.
NAD+: The Cellular Energy Currency
Nicotinamide Adenine Dinucleotide (NAD+) is a coenzyme found in all living cells. It plays critical roles in:
- Energy metabolism and mitochondrial function
- DNA repair processes
- Gene expression regulation through sirtuins (longevity genes)
- Cellular signaling pathways
- Maintaining cellular health and function
NAD+ levels naturally decline with age—by up to 50% between our 20s and 80s. This decline has been associated with various hallmarks of aging and age-related conditions.
NAD+ Precursors: Different Paths to the Same Goal
The body can produce NAD+ through several pathways, including de novo synthesis (from tryptophan) and salvage pathways that recycle various precursors. NMN and NR are both involved in these salvage pathways but enter at different points.
NMN (Nicotinamide Mononucleotide)
NMN is a nucleotide derived from ribose and nicotinamide. Key characteristics include:
- Larger molecular structure (molecular weight: 334.2 g/mol)
- One step away from NAD+ in the metabolic pathway
- Converted to NAD+ by the enzyme NMN adenylyltransferase (NMNAT)
- Found naturally in small amounts in foods like broccoli, avocado, and edamame
NR (Nicotinamide Riboside)
NR is a pyridine-nucleoside form of vitamin B3 (niacin). Key characteristics include:
- Smaller molecular structure (molecular weight: 255.2 g/mol)
- Two steps away from NAD+ (must convert to NMN first)
- Converted to NMN by the enzyme NR kinases (NRKs)
- Found in trace amounts in milk and possibly other foods
Biochemical Differences: How They Work in Your Body
While both NMN and NR ultimately increase NAD+ levels, their different chemical structures and positions in the NAD+ biosynthesis pathway result in some important biochemical distinctions.
Absorption and Bioavailability
One of the most significant differences between NMN and NR relates to how they’re absorbed and transported in the body:
NMN Absorption
- Size Considerations: Historically, NMN’s larger size was thought to prevent direct absorption, requiring conversion to NR first. However, recent research has identified specific NMN transporters (Slc12a8) in the small intestine, suggesting direct uptake is possible.
- Transport Mechanisms: Once in the bloodstream, NMN appears to be rapidly taken up by tissues, though the exact mechanisms may vary between tissue types.
- Blood Stability: NMN may be partially degraded in the bloodstream, though modern formulations aim to improve stability.
NR Absorption
- Size Advantage: NR’s smaller molecular size has been considered advantageous for intestinal absorption.
- Transport Mechanisms: NR appears to enter cells via specific nucleoside transporters.
- Blood Stability: In the bloodstream, NR can be metabolized to nicotinamide (NAM) before reaching target tissues.
Tissue Distribution and Cellular Uptake
The distribution of NMN and NR throughout the body and their uptake by different tissues may not be identical:
NMN Distribution
- Some research suggests NMN may more readily cross the blood-brain barrier once converted to nicotinamide riboside
- May have particularly strong effects in metabolically active tissues like liver, muscle, and adipose tissue
- Specific NMN transporters have been identified in the intestine and potentially other tissues
NR Distribution
- Well-studied for its ability to enter various cell types
- May more efficiently enter certain neuronal cell types
- Distribution appears to be fairly broad throughout tissues
Metabolic Conversion to NAD+
The pathway to NAD+ differs between the two compounds:
NMN Conversion Pathway
- Single enzymatic step: NMN → NAD+ (via NMNAT enzymes)
- May potentially bypass rate-limiting steps in certain tissues
- Some evidence suggests direct phosphorylation may be possible in some cell types
NR Conversion Pathway
- Two enzymatic steps: NR → NMN → NAD+ (via NRK1/2 then NMNAT)
- The NRK enzyme activity may be rate-limiting in some tissues
- May utilize different intracellular compartmentalization than NMN
NMN
Nicotinamide Mononucleotide
Molecular Weight: 334.2 g/mol
Steps to NAD+: 1 step
Key Enzymes: NMNAT
NR
Nicotinamide Riboside
Molecular Weight: 255.2 g/mol
Steps to NAD+: 2 steps
Key Enzymes: NRK1/2, NMNAT
These biochemical differences may have practical implications for supplementation strategies, though their clinical significance is still being investigated. The “ideal” precursor may depend on individual factors like age, health status, and the specific tissues you’re targeting.
Research Comparison: What Science Says
The scientific literature on NMN and NR has expanded significantly in recent years. Let’s compare the research evidence for each compound.
Research Timeline and Volume
The historical development of research for these compounds differs:
- NR Research: NR’s role in NAD+ metabolism was discovered earlier (2004 by Dr. Charles Brenner), giving it a head start in research. It has more completed human clinical trials to date.
- NMN Research: While NMN has been studied for decades, intensive research accelerated in the 2010s, particularly following Dr. David Sinclair’s work. Human research is newer but expanding rapidly.
In terms of sheer volume, published studies on NR slightly outnumber those on NMN in humans, though NMN research is growing at a faster rate in recent years.
Animal Studies: Where They Differ
Animal research provides our most comprehensive view of the potential effects of these compounds, though translation to humans requires caution.
NMN in Animal Models
NMN has shown numerous beneficial effects in rodent studies:
- Lifespan: Long-term NMN administration mitigated age-associated physiological decline in mice
- Metabolism: Improved insulin sensitivity, glucose tolerance, and mitochondrial function
- Cardiovascular: Enhanced vascular function and cardiac protection
- Neurological: Improved cognitive function and potential neuroprotection
- Exercise Performance: Increased endurance and energy metabolism in skeletal muscle
NR in Animal Models
NR has similarly demonstrated beneficial effects in animal research:
- Lifespan: Extended lifespan in some models, though results vary by species and conditions
- Metabolism: Improved metabolic health, particularly in models of obesity and diabetes
- Cardiovascular: Reduced blood pressure and improved cardiac function in some models
- Neurological: Neuroprotection in models of neurodegenerative diseases
- Muscle Function: Improved mitochondrial function and stem cell activity in aged muscle
Comparative Animal Studies
Few studies have directly compared NMN and NR in the same animal models, but those that have suggest:
- Both effectively raise NAD+ levels in multiple tissues
- NMN may achieve higher peak NAD+ levels in some tissues
- NR may have advantages in crossing the blood-brain barrier in some models
- Effects may be tissue-specific and context-dependent
Overall, animal research suggests both compounds have promising effects, with potentially different strengths in different tissues or conditions.
Human Research: The Current Evidence
Human clinical trials provide the most relevant data for making supplementation decisions, though this research is still evolving for both compounds.
NMN Human Studies
Human research on NMN is newer but growing quickly:
- Safety: Studies confirm safety and tolerability up to 1200mg/day
- Metabolism: Improved insulin sensitivity in women with prediabetes (250mg/day for 10 weeks)
- Physical Performance: Enhanced aerobic capacity in runners (1200mg/day for 12 weeks)
- Bioavailability: Demonstrated increases in NAD+ metabolites after oral dosing
NR Human Studies
NR has a larger body of completed human trials:
- Safety: Confirmed safety at doses up to 2000mg/day
- NAD+ Boosting: Reliably increases NAD+ levels in blood cells and tissues
- Cardiovascular: Some studies show modest improvements in blood pressure and arterial stiffness
- Metabolism: Mixed results on insulin sensitivity and body composition
- Exercise: Some benefits for muscle metabolism and mitochondrial function
| Aspect | NMN Human Evidence | NR Human Evidence |
|---|---|---|
| Number of published clinical trials | ~10 completed trials | ~20 completed trials |
| Dosage range studied | 100mg – 1200mg daily | 100mg – 2000mg daily |
| Longest study duration | 24 weeks | 12 months |
| Most consistent effects | Insulin sensitivity, physical performance | NAD+ increase, cardiovascular parameters |
| Safety profile | Generally well-tolerated | Generally well-tolerated |
While NR currently has more completed human trials, the quality and relevance of studies matter more than quantity. Both compounds show promising effects, with potentially different strengths in different domains.
Most human studies on both NMN and NR have limitations that should be considered:
- Relatively small sample sizes (typically 10-50 participants)
- Short study durations (typically weeks to months)
- Varying populations (healthy, elderly, metabolically impaired)
- Different endpoints and measurement techniques
- Limited direct comparisons between the two compounds
These limitations make direct comparisons challenging and highlight the need for larger, longer-term clinical trials.
Head-to-Head Comparison: NMN vs. NR
Based on the current scientific literature and practical considerations, here’s a direct comparison of NMN and NR across key dimensions:
| Factor | NMN | NR | Verdict |
|---|---|---|---|
| Human research volume | Moderate, growing rapidly | Larger body of evidence | NR leads but gap narrowing |
| NAD+ boosting efficiency | Potentially higher peak levels | Well-established increases | Both effective, may be tissue-dependent |
| Metabolic effects | Strong evidence in animal and early human studies | Mixed results in human studies | NMN may have slight edge |
| Cardiovascular effects | Strong in animal models, limited human data | Promising human evidence for blood pressure | NR has more human evidence |
| Neurological effects | Promising animal data, human studies ongoing | Good animal data, limited human studies | Both promising, needs more human research |
| Physical performance | Positive results in early human trials | Mixed results in human studies | NMN showing promise |
| Bioavailability | Requires specific transporters | Smaller molecule may aid absorption | Both have viable absorption pathways |
| Stability | More sensitive to environmental conditions | Generally more stable | NR has practical advantage |
| Cost per effective dose | Generally higher | Generally lower | NR more cost-effective currently |
This comparison suggests that both compounds have distinct advantages and potential applications, with neither being universally superior for all purposes.
NMN Pros & Cons
Pros:
- One step closer to NAD+ in the metabolic pathway
- Promising results for metabolic health in early human trials
- May achieve higher peak NAD+ levels in some tissues
- Emerging evidence for exercise performance benefits
- Rapidly expanding research base
Cons:
- Generally more expensive per dose
- Fewer completed human clinical trials
- More stability challenges (temperature, moisture)
- Larger molecule may face absorption challenges
- More variable product quality in marketplace
NR Pros & Cons
Pros:
- More human clinical research available
- Generally lower cost per effective dose
- Better product standardization and quality control
- More stable in various environmental conditions
- Smaller molecule may have absorption advantages
Cons:
- Requires two-step conversion to NAD+
- Mixed results in some human metabolic studies
- May not achieve same peak NAD+ levels in all tissues
- Can be rapidly metabolized to nicotinamide in blood
- Limited direct comparison studies with NMN
Practical Considerations: Cost, Dosage, and Availability
Beyond the scientific evidence, several practical factors may influence your choice between NMN and NR.
Cost Comparison
Cost remains a significant consideration for many people:
- NMN: Typically ranges from $1-3 per day at commonly used doses (250-500mg)
- NR: Generally ranges from $1-2 per day at commonly used doses (300-500mg)
NR tends to be more affordable, though NMN prices have decreased as manufacturing has scaled up. Premium brands of both supplements command higher prices, often justified by better quality assurance and testing.
Effective Dosages
Based on clinical research, these dosage ranges appear effective:
- NMN: 250-1200mg daily, with most human studies using 250-500mg
- NR: 300-1000mg daily, with most human studies using 300-500mg
Higher doses don’t necessarily provide proportionally greater benefits, as NAD+ boosting effects may plateau. Starting at the lower end of these ranges is reasonable for most people.
Quality and Product Selection
Product quality varies significantly:
- NMN: More variable in the marketplace, with purity concerns from some manufacturers. Look for products specifying >98% purity with third-party testing.
- NR: More standardized, with patented forms like Niagen® dominating the market. Generally more consistent quality across products.
For both supplements, look for:
- Third-party testing for purity and potency
- Appropriate packaging (moisture and light protection)
- Manufacturing in cGMP-certified facilities
- Transparency about sourcing and testing
Stability and Storage
Stability differences may affect product selection and storage:
- NMN: More sensitive to environmental conditions. Requires cool, dry storage, ideally in airtight containers. Some products use specialized packaging or enteric coatings to improve stability.
- NR: Generally more stable at room temperature and less sensitive to moisture. Standard supplement packaging usually provides adequate protection.
Regardless of which you choose, store in a cool, dry place away from direct sunlight for maximum potency.
Who Benefits Most: Matching Supplements to Goals
Your specific health goals and circumstances may make one NAD+ precursor more suitable than the other:
NMN May Be Preferred For:
- Metabolic Health: Those primarily concerned with insulin sensitivity and glucose regulation, given the promising results in this area
- Athletic Performance: Individuals seeking potential improvements in exercise capacity, based on recent human trials
- Maximum NAD+ Elevation: Those wanting to achieve the highest possible NAD+ levels in certain tissues
- Combination with Resveratrol: If following protocols similar to those researched by Dr. David Sinclair
NR May Be Preferred For:
- Cardiovascular Health: Individuals primarily concerned with blood pressure and vascular function, given the more established human evidence
- Budget Considerations: Those seeking a more cost-effective NAD+ booster
- Evidence-Based Approach: Those who prefer interventions with more completed human clinical trials
- Stability/Convenience: People concerned about supplement stability or who travel frequently
Age-Related Considerations
Age may also influence which precursor is more suitable:
- Middle Age (40-60): Both precursors may be equally effective, as multiple NAD+ pathways remain functional
- Older Adults (60+): Some research suggests NMN might have advantages in older individuals as certain NR-processing enzymes may decline with age
- Athletes: Emerging research suggests NMN may have specific benefits for mitochondrial function during exercise
Which NAD+ Precursor Might Be Right For You?
Consider which statement best matches your situation:
1. Your primary concern is:
2. Your budget priority is:
3. Your approach to supplementation is:
The Combination Approach: Can You Take Both?
Some longevity enthusiasts and researchers have begun exploring combination or cycling approaches with both NMN and NR.
Potential Synergies
Theoretical advantages of combination approaches include:
- Activating multiple NAD+ biosynthesis pathways simultaneously
- Potentially achieving more comprehensive tissue distribution
- Leveraging the distinct advantages of each molecule
- Possibility of using lower doses of each while maintaining benefits
Cycling Strategies
Some protocols involve cycling between NMN and NR:
- Alternating Days: NMN one day, NR the next
- Weekly Rotation: One week of NMN followed by one week of NR
- Seasonal Approaches: Using one compound for several months before switching
The rationale behind cycling includes preventing potential downregulation of NAD+ pathways and leveraging different mechanisms of action.
Practical Combination Approaches
For those considering using both compounds:
- Start with one compound at a time to assess individual response
- Consider using lower doses of each when combining (e.g., 250mg NMN + 250mg NR instead of 500mg of either alone)
- Monitor subjective effects and any biomarkers you’re tracking
- Consider cost implications, as using both supplements will be more expensive
It’s important to note that formal research on combination approaches is extremely limited. The potential benefits of combining or cycling NMN and NR remain theoretical and based on mechanistic reasoning rather than clinical evidence. As with any experimental approach, proceed with appropriate caution.
Future Research: What’s on the Horizon
The field of NAD+ precursor research is evolving rapidly, with several exciting developments on the horizon:
Ongoing Clinical Trials
Numerous clinical trials are in progress or planning stages:
- Large-scale, longer-term studies (1+ years) of both compounds
- Investigation of effects on cognitive function and brain health
- Research on specific age-related conditions
- Studies in more diverse populations and age groups
- Direct comparative trials between NMN and NR
Delivery Innovations
New formulation technologies aim to enhance effectiveness:
- Liposomal and nanoparticle delivery systems
- Sustained-release formulations
- Tissue-targeted delivery approaches
- Co-formulations with complementary compounds
Novel NAD+ Boosters
Beyond NMN and NR, researchers are investigating other compounds that may influence NAD+ metabolism:
- Dihydronicotinamide riboside (NRH)
- NAD+ precursor combinations
- CD38 inhibitors to reduce NAD+ consumption
- PARP inhibitors that preserve NAD+
Personalized Approaches
Future research may enable more individualized recommendations:
- Genetic testing to identify optimal NAD+ precursors
- Biomarker-guided dosing strategies
- Age-specific protocols
- Integration with other personalized interventions
These developments suggest that our understanding of NAD+ precursors and their optimal use will continue to evolve significantly in the coming years.
Conclusion: Making Your Decision
The Bottom Line: NMN vs. NR
Both NMN and NR represent promising approaches to boosting NAD+ levels and potentially supporting healthy aging. Neither compound is universally “better” than the other—each has distinct properties, research support, and potential applications.
The right choice depends on your specific health goals, preferences, budget, and individual response. For some, a combination or cycling approach may provide additional benefits, though this remains speculative until more research emerges.
As with any supplement strategy, start with realistic expectations, prioritize quality products, and consider NAD+ precursors as just one component of a comprehensive approach to healthy aging that includes proper nutrition, exercise, stress management, and sleep optimization.
Key Recommendations:
- Quality First: Regardless of which precursor you choose, prioritize high-quality products with third-party testing and appropriate purity levels
- Start Conservative: Begin with lower doses (250-300mg daily) and assess your response before considering higher doses
- Consistency Matters: NAD+ precursors typically require consistent use over time to achieve optimal effects
- Track Results: Consider monitoring relevant biomarkers and subjective effects to gauge your personal response
- Stay Informed: Keep up with emerging research, as our understanding of these compounds continues to evolve rapidly
- Integrated Approach: Remember that NAD+ precursors work best as part of a comprehensive longevity strategy, not as a standalone “magic bullet”
The NAD+ precursor field represents one of the most promising and rapidly evolving areas of longevity research. Whether you choose NMN, NR, or a combination approach, you’re engaging with cutting-edge science that may help support healthier aging in the years ahead.
As research continues to evolve, the “NMN vs. NR debate” will likely become more nuanced, with clearer guidance on which compound is optimal for specific individuals and health goals. Until then, making an informed choice based on the current evidence and your personal priorities remains the best approach.
References
- Yoshino, J., Baur, J. A., & Imai, S. I. (2018). NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR. Cell metabolism, 27(3), 513–528.
- Trammell, S. A., Schmidt, M. S., Weidemann, B. J., et al. (2016). Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nature communications, 7, 12948.
- Grozio, A., Mills, K. F., Yoshino, J., et al. (2019). Slc12a8 is a nicotinamide mononucleotide transporter. Nature metabolism, 1(1), 47–57.
- Yoshino, M., Yoshino, J., Kayser, B. D., et al. (2021). Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science, 372(6547), 1224–1229.
- Martens, C. R., Denman, B. A., Mazzo, M. R., et al. (2018). Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nature communications, 9(1), 1286.
- Mills, K. F., Yoshida, S., Stein, L. R., et al. (2016). Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice. Cell metabolism, 24(6), 795–806.
- Dollerup, O. L., Christensen, B., Svart, M., et al. (2018). A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects. The American journal of clinical nutrition, 108(2), 343–353.
- Liao, B., Zhao, Y., Wang, D., et al. (2022). Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study. Journal of the International Society of Sports Nutrition, 19(1), 41–53.
- Elhassan, Y. S., Kluckova, K., Fletcher, R. S., et al. (2019). Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD+ Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures. Cell reports, 28(7), 1717–1728.e6.
- Hong, W., Mo, F., Zhang, Z., et al. (2020). Nicotinamide Mononucleotide: A Promising Molecule for Therapy of Diverse Diseases by Targeting NAD+ Metabolism. Frontiers in cell and developmental biology, 8, 246.
- Remie, C. M. E., Roumans, K. H. M., Moonen, M. P. B., et al. (2020). Nicotinamide riboside supplementation alters body composition and skeletal muscle acetylcarnitine concentrations in healthy obese humans. The American journal of clinical nutrition, 112(2), 413–426.
- Liu, L., Su, X., Quinn, W. J., 3rd, et al. (2018). Quantitative Analysis of NAD Synthesis-Breakdown Fluxes. Cell metabolism, 27(5), 1067–1080.e5.
